Tilray Brands (TLRY) Non Operating Income (2017 - 2026)
Tilray Brands (TLRY) reported Non Operating Income of $8.1 million for Q1 2026, up 133.69% on a YoY basis from $3.5 million in Q1 2025, and up 165.74% quarter-over-quarter from -$12.3 million in Q4 2025.
Tilray Brands (TLRY) Non Operating Income (2017 - 2026) Analysis & Trends
Tilray Brands has reported Non Operating Income for 10 years, with the latest figure at $8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 133.69% year-over-year to $8.1 million; the trailing twelve-month figure through Feb 2026 stood at $54.5 million (up 188.45% YoY), and the FY2025 full-year result was $10.3 million, up 127.18% from the prior year.
- Non Operating Income for Q1 2026 stood at $8.1 million, up from -$12.3 million in the prior quarter.
- The five-year high for Non Operating Income was $71.0 million in Q1 2022, with the low at -$33.3 million in Q4 2024.
- Historically, Non Operating Income has averaged $1.7 million across 5 years, with a median of $821000.0 in 2023.
- The largest YoY upside for Non Operating Income was 38498.38% in 2022 against a maximum downside of 17373.3% in 2022.
- Tilray Brands' Non Operating Income stood at -$18.4 million in 2022, then soared by 104.45% to $821000.0 in 2023, then slumped by 4150.55% to -$33.3 million in 2024, then soared by 62.98% to -$12.3 million in 2025, then soared by 165.74% to $8.1 million in 2026.
- The last three Non Operating Income figures came in at $8.1 million (Q1 2026), -$12.3 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 8.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 8.09 Mn |
| Nov 30, 2025 | -12.31 Mn |
| Aug 31, 2025 | 3.83 Mn |
| May 31, 2025 | 54.92 Mn |
| Feb 28, 2025 | -24.02 Mn |
| Nov 30, 2024 | -33.26 Mn |
| Aug 31, 2024 | 12.65 Mn |
| May 31, 2024 | -17.02 Mn |
| Feb 29, 2024 | -17.24 Mn |
| Nov 30, 2023 | 821,000.00 |
| Aug 31, 2023 | -4.40 Mn |
| May 31, 2023 | 24.37 Mn |
| Feb 28, 2023 | 1.21 Mn |
| Nov 30, 2022 | -18.45 Mn |
| Aug 31, 2022 | -32.99 Mn |
| May 31, 2022 | 11.34 Mn |
| Feb 28, 2022 | 71.04 Mn |
| Nov 30, 2021 | 65.60 Mn |
| Aug 31, 2021 | 191,000.00 |
| May 31, 2021 | -24.39 Mn |